🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/05/2015 | 57,68 | 57,81 | 57,19 | 57,50 | -0,38% | 1,09% | 12.126.303 |
| 05/05/2015 | 57,56 | 57,92 | 57,31 | 57,72 | -0,25% | 1,06% | 12.662.041 |
| 04/05/2015 | 57,39 | 58,16 | 57,28 | 57,86 | +1,30% | 1,53% | 9.484.819 |
| 01/05/2015 | 57,02 | 57,61 | 56,95 | 57,12 | +0,50% | 1,17% | 9.806.660 |
| 30/04/2015 | 57,05 | 57,39 | 56,53 | 56,83 | -0,20% | 1,51% | 13.636.995 |
| 29/04/2015 | 56,61 | 57,66 | 56,52 | 56,95 | -0,50% | 2,02% | 18.017.216 |
| 28/04/2015 | 54,48 | 57,71 | 54,48 | 57,23 | +5,04% | 5,92% | 36.398.298 |
| 27/04/2015 | 55,18 | 55,37 | 54,27 | 54,48 | -0,87% | 1,99% | 11.108.381 |
| 24/04/2015 | 55,20 | 55,52 | 54,88 | 54,96 | +0,16% | 1,18% | 8.244.092 |
| 23/04/2015 | 54,89 | 55,20 | 54,43 | 54,88 | -0,31% | 1,41% | 8.742.416 |
| 22/04/2015 | 54,92 | 55,24 | 54,69 | 55,05 | +0,05% | 0,99% | 8.294.501 |
| 21/04/2015 | 55,35 | 55,37 | 54,78 | 55,02 | +0,09% | 1,07% | 9.699.764 |
| 20/04/2015 | 54,87 | 55,34 | 54,76 | 54,97 | +1,28% | 1,06% | 10.439.547 |
| 17/04/2015 | 54,72 | 54,73 | 53,98 | 54,27 | -1,66% | 1,38% | 12.223.243 |
| 16/04/2015 | 55,54 | 55,72 | 55,10 | 55,19 | -1,04% | 1,12% | 6.717.051 |
| 15/04/2015 | 55,41 | 56,25 | 55,41 | 55,77 | +1,19% | 1,52% | 12.690.022 |
| 14/04/2015 | 54,33 | 55,33 | 54,02 | 55,11 | +1,82% | 2,42% | 15.359.698 |
| 13/04/2015 | 54,47 | 54,74 | 53,91 | 54,13 | -0,91% | 1,52% | 10.983.983 |
| 10/04/2015 | 54,44 | 55,01 | 53,74 | 54,63 | -0,31% | 2,33% | 16.251.860 |
| 09/04/2015 | 54,60 | 55,09 | 54,49 | 54,80 | +0,49% | 1,08% | 12.582.288 |
| 08/04/2015 | 55,26 | 55,39 | 54,41 | 54,53 | -0,49% | 1,78% | 14.210.566 |
| 07/04/2015 | 55,02 | 55,23 | 54,68 | 54,80 | +0,44% | 1,01% | 9.723.658 |
| 06/04/2015 | 54,32 | 54,71 | 54,11 | 54,56 | +0,14% | 1,11% | 13.256.362 |
| 02/04/2015 | 54,39 | 54,82 | 54,25 | 54,48 | +0,42% | 1,05% | 7.947.508 |
| 01/04/2015 | 54,64 | 54,69 | 53,65 | 54,26 | -1,08% | 1,92% | 13.322.386 |
| 31/03/2015 | 55,52 | 55,64 | 54,85 | 54,85 | -1,47% | 1,43% | 10.960.718 |
| 30/03/2015 | 55,58 | 55,86 | 55,49 | 55,67 | +1,02% | 0,67% | 8.582.072 |
| 27/03/2015 | 55,18 | 55,56 | 54,99 | 55,11 | +0,26% | 1,04% | 8.932.628 |
| 26/03/2015 | 55,38 | 55,53 | 54,78 | 54,96 | -1,13% | 1,36% | 11.090.879 |
| 25/03/2015 | 56,77 | 56,98 | 55,52 | 55,59 | -0,63% | 2,57% | 14.712.243 |